Fomulary implications for the management of multidrug-resistant organisms.
Clark
Thomas R
TR
American Society of Consultant Pharmacists, Alexandria, VA, USA.
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003428:Cross Infection / Q000517:prevention & control; D024901:Drug Resistance, Multiple, Bacterial; D017723:Drug Utilization Review; D005569:Formularies as Topic; D017408:Guidelines as Topic; D006268:Health Facilities / Q000592:standards*; D006801:Humans; D017053:Infection Control; D008484:Medicaid; D006278:Medicare; D014481:United States
D000900:Anti-Bacterial Agents